Coherus BioSciences Inc Financial Flexibility Index
Coherus BioSciences Inc financial flexibility index. Coherus BioSciences Inc (CHRS) has a Financial Flexibility Index of -0.92x as of June 2026. Free cash flow of $-119.98 Million (operating CF $-119.98 Million minus capex $0.00) represents -1% of total liabilities ($130.34 Million). See Coherus BioSciences Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Coherus BioSciences Inc (2012–2025)
Financial flexibility index of Coherus BioSciences Inc from 2012 to 2025. Historical Financial Flexibility Index trend for Coherus BioSciences Inc across 14 annual periods. Check Coherus BioSciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Coherus BioSciences Inc Financial Flexibility Index by Year (2012–2025)
Coherus BioSciences Inc financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Coherus BioSciences Inc. For the full cash flow conversion analysis, see CHRS cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | $-138.51 Million | $-138.51 Million | $197.33 Million | ▼ -1893.6% |
| 2024 | -0.04x | $-20.44 Million | $-20.44 Million | $580.52 Million | ▲ +83.4% |
| 2023 | -0.21x | $-174.60 Million | $-174.88 Million | $823.03 Million | ▲ +45.1% |
| 2022 | -0.39x | $-239.09 Million | $-241.12 Million | $618.26 Million | ▼ -522.3% |
| 2021 | -0.06x | $-36.14 Million | $-37.43 Million | $581.61 Million | ▼ -121.6% |
| 2020 | 0.29x | $161.38 Million | $154.15 Million | $560.67 Million | ▲ +111.9% |
| 2019 | 0.14x | $41.25 Million | $28.36 Million | $303.71 Million | ▲ +111.8% |
| 2018 | -1.15x | $-158.48 Million | $-159.27 Million | $138.06 Million | ▲ +22.5% |
| 2017 | -1.48x | $-195.71 Million | $-200.29 Million | $132.08 Million | ▲ +4.2% |
| 2016 | -1.55x | $-246.03 Million | $-252.54 Million | $159.13 Million | ▼ -233.0% |
| 2015 | -0.46x | $-101.83 Million | $-107.99 Million | $219.31 Million | ▼ -165.4% |
| 2014 | -0.17x | $-21.08 Million | $-23.93 Million | $120.46 Million | ▼ -199.5% |
| 2013 | 0.18x | $15.80 Million | $15.42 Million | $89.83 Million | ▲ +118.5% |
| 2012 | -0.95x | $-16.47 Million | $-18.25 Million | $17.34 Million | — |